Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05089292 · ClinicalTrials.gov registry record · NA
Increasing Breast Cancer Screening in Chinese Immigrants
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT05089292 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 99 participants.
The verdict
NCT05089292, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
The long-term goal of this research is to increase breast cancer screening rates in NYC Chinese immigrants. The researchers plan to accomplish this objective by developing and testing a culturally- and linguistically-adapted Witness Project program for Chinese immigrants. To inform the intervention development, the study team will identify barriers and facilitators to breast cancer screening in Chinese immigrants through individual qualitative interviews. A total of 156 participants will be recruited during the entire study. In Aim 1 which started in July 2021, 60 women were recruited for in-depth interviews to assess their breast cancer knowledge, perceived barriers and benefits/risks to completing mammography, perceived susceptibility to breast cancer, fatalism, screening intention, acculturation, language preference, and health literacy. In Aim 2, 96 women will be recruited to participate in the pilot testing of the intervention. Recruitment will take place at community sites that serve Chinese immigrants in New York City. Enrollment for Aim 2 is anticipated to start in March of 2022.
Interventions
- BEHAVIORAL Narrative breast health education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2022-12-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05089292
The ClinicalTrials.gov registry entry for NCT05089292 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Narrative breast health education is the first listed.
NCT05089292 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05089292 about?
NCT05089292 is a clinical study titled "Increasing Breast Cancer Screening in Chinese Immigrants". The long-term goal of this research is to increase breast cancer screening rates in NYC Chinese immigrants. The researchers plan to accomplish this objective by developing and testing a culturally- and linguistically-adapted Witness Project program for Chinese immigrants. To inform the intervention ...
What is the current status of trial NCT05089292?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2021-07-01. Estimated completion is 2022-12-13.
What interventions are being tested in trial NCT05089292?
The interventions under investigation include: Narrative breast health education (BEHAVIORAL).
Who is sponsoring clinical trial NCT05089292?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.